Increased METTL3 expression is associated with advanced T stage, poor tumour differentiation, lymphatic metastasis, and a poor overall survival rate in HNSCC and OSCC (12,13,18,19). The gene discussed is METTL3; the disease is head and neck squamous cell carcinoma.